Could Risk Stratifying MTX Users Lead to Testing Less Often?

A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical application, experts say.

Related Keywords

Nottingham , United Kingdom , California , United States , Abhishek , Los Angeles , Prabha Ranganathan , Daniele Furst , Nottingham University Hospitals , University Of California , United Kingdom Clinical Practice Research Datalink , More Research , Washington University School Of Medicine , Clinical Practice Research Datalink , Medscape Medical News , Hospital Rheumatoid Arthritis Sequential Study , Washington University School , Toxicology , Blood , Complete Blood Count Cbc , Ull Blood Count Fbc , Ull Blood Exam Fbe , Blood Panel , United Kingdom Site Content , Rheumatoid Arthritis , A , Uk National Health Service , United Kingdom National Health Service , K Nhs , Dhs , National Health Service , Chronic Renal Failure , Hronic Kidney Failure , Hronic Kidney Disease Ckd , Chronic Kidney Disease , Kd , Renal Failure , Enal Insufficie ,